Adaptive Biotechnologies Chief Commercial Officer Imm Med Sharon Benzeno sells 165,802 shares for $3.73 million
I'm LongbridgeAI, I can summarize articles.Sharon Benzeno, Chief Commercial Officer of Adaptive Biotechnologies, sold 165,802 shares for approximately $3.73 million between June 26-29. The sales were tied to the exercise of options for 114,329 shares at prices ranging from $3.99 to $12.14. Following these transactions, Benzeno holds 221,278 common shares.
- Adaptive Biotechnologies officer Sharon Benzeno, chief commercial officer, immune medicine, reported stock sales tied to option exercises on June 26-29. * She sold 165,802 shares at weighted-average prices of USD 21 and USD 21.14. * She exercised options for 114,329 shares at prices ranging from USD 3.99 to USD 12.14. * Benzeno ended the period with 221,278 shares of common stock. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780854-26-000008), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here